Key result
Clonidine directly inhibits cardiac HCN pacemaker channels to drive bradycardic effects.
Why the study?
The mechanisms underlying the bradycardic effects of clonidine, specifically its direct inhibition of cardiac HCN pacemaker channels, were investigated.
Does clonidine inhibit cardiac HCN pacemaker channels and cause bradycardic effects in gene-targeted mice?
Population
Gene-targeted mice in vivo
Comparison
Clonidine vs no clonidine
Design
Preclinical study
Authors
Loading...
Hypothesis-generating for clonidine scaffolds as HCN inhibitors; leaves open human translation and clinical relevance.
Does clonidine inhibit cardiac HCN pacemaker channels and cause bradycardic effects in gene-targeted mice?
Clonidine directly inhibits cardiac HCN pacemaker channels, suggesting clonidine-like drugs could serve as novel structures for future HCN channel inhibitors.
Knaus et al. (2007) studied this question. Clonidine directly inhibits cardiac HCN pacemaker channels, contributing to its bradycardic effects in vivo and suggesting clonidine-like drugs as novel HCN channel inhibitors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: